Dorsey Wright & Associates’s PAVmed PAVM Stock Holding History

Dorsey Wright & Associates’s Portfolio PAVM Stock Details PAVM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-18	Closed	-$68K	–	320
2021 Q3	$68K	Buy	18 +2	+13%	+$6.31K	0.01%	159
2021 Q2	$47K	Buy	+16	New	+$37.8K	0.01%	211

Other funds holding PAVM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Dorsey Wright & Associates's PAVM Position: Q4 2021 in Review

Dorsey Wright & Associates sold out of PAVmed (PAVM) in Q4 2021, closing a stake of 18 shares — an estimated $68K sold.

Dorsey Wright & Associates first reported a position in PAVM in Q2 2021 and held it in 2 quarters. The position peaked at $68K in Q3 2021. 105 funds tracked by Wall St. Rank hold PAVM as of Q4 2021.

Dorsey Wright & Associates reported no remaining PAVmed position as of Q4 2021 after selling out during the quarter.
Dorsey Wright & Associates sold 18 PAVmed shares in Q4 2021, an estimated $68K.
Dorsey Wright & Associates first reported a position in PAVmed in Q2 2021 and held it in 2 quarters.
Dorsey Wright & Associates's PAVmed position peaked at $68K in Q3 2021.
105 funds tracked by Wall St. Rank held PAVmed as of Q4 2021.

Based on Dorsey Wright & Associates's 13F filing for Q4 2021, filed 27 Jan 2022.